Sansure Biotech Inc. (SHA:688289)
China · Delayed Price · Currency is CNY 21.29
-0.13 (-0.61%)
Jul 18, 2025, 3:00 PM CST
Sansure Biotech Market Cap
Sansure Biotech has a market cap or net worth of 12.22 billion as of July 18, 2025. Its market cap has increased by 16.34% in one year.
Market Cap
12.22B
Enterprise Value
8.66B
Revenue
1.54B
Ranking
n/a
PE Ratio
43.50
Stock Price
21.29
Market Cap Chart
Since August 28, 2020, Sansure Biotech's market cap has decreased from 46.42B to 12.22B, a decrease of -73.67%. That is a compound annual growth rate of -23.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 12.22B | -5.97% |
| Dec 31, 2024 | 13.00B | 16.22% |
| Dec 29, 2023 | 11.19B | -12.24% |
| Dec 30, 2022 | 12.75B | -45.99% |
| Dec 31, 2021 | 23.60B | -48.22% |
| Dec 31, 2020 | 45.58B | -1.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 381.37B |
| Shenzhen Mindray Bio-Medical Electronics | 262.66B |
| WuXi AppTec | 231.56B |
| Sichuan Biokin Pharmaceutical | 120.65B |
| Zhangzhou Pientzehuang Pharmaceutical., | 119.55B |
| Aier Eye Hospital Group | 114.24B |
| Shanghai United Imaging Healthcare | 102.75B |
| Yunnan Baiyao Group Co.,Ltd | 99.76B |